Table 5 In-hospital management (n = 200)
From: COVID-19 related deaths in an urban academic medical center in Brooklyn – a descriptive case series
Length of hospital staya; median (IQR), days | 4·25 (2·26–6·93) |
Total duration of symptoms prior to expiration,b median (IQR), days | 8·42 (5·57–12·72) |
Expiration more than 7 days following symptom, (n, %) | 127 (63·5) |
Code Status (n, %) | |
Full code until expiration | 113 (56·5) |
DNR order in place at admission | 50 (25) |
Made DNR during admission | 37 (18·5) |
Made DNR following intubation | 11 |
Total ICU Admissions (n, %) | 55 (27·5) |
Intubated during stay (n, %) | 70 (35) |
Intubations performed in emergency department (ED) (n = 70) (n, %) | 30 (42·9) |
Time to intubation if not intubated in ED, median (IQR) (n = 40), hours | 57 (35–96) |
O2 therapy prior to intubation if not intubated in ED (n = 40) | |
Nasal cannula (n, %) | 19 (47·5) |
Non-rebreather | 13 (32·5) |
BIPAP | 6 (15) |
CPAP | 1 (2·5) |
Room air | 1 (2·5) |
Prone positioning (n, %) | 1 (0·5) |
Anticoagulation | |
Thromboprophylaxis | |
Heparin (n, %) | 102 (51) |
Enoxaparin | 59 (29·5) |
Fondaparinux | 1 (0·5) |
Full dose anticoagulation | |
Heparin or enoxaparin | 11 (5·5) |
Continued home medications | 10 (5) |
No anticoagulation | |
Length of stay too short | 10 (5) |
Elevated INR | 3 (1·5) |
History of GI bleed | 3 (1·5) |
Comfort measures only | 1 (0·5) |
Hemodialysis new start, n = 186 (n, %)c | 18 (9·7) |